Kovatcheva et al. recently reported that palbociclib treatment induces cellular senescence in human liposarcoma LS8817 cells through the formation of senescence-associated heterochromatic foci (SAHF), which are mediated by the recruitment of the chromatin-remodeling enzyme ATRX into PML-NBs [41]. The gene discussed is ATRX; the disease is liposarcoma.